27.02.2025 • News

Arkema to Increase its PVDF Capacity in North America

The 15% capacity expansion of Arkema’s PVDF production site in Calvert City, Kentucky, represents an investment of approximately $20 million (€19 million).

This expansion will focus on innovative PVDF grades to support the manufacture of electric vehicles (EV) and energy storage systems, and growth in local manufacturing for other strategic markets. The startup is planned for mid-2026, aligning with the production ramp-up at North American gigafactories and the expansion of local semiconductor capabilities.

"We are proud to take this step forward hand-in-hand with our customers," commented Laurent Tellier,
Senior Vice-President of Arkema’s High Performance Polymers and Fluorogases. "It demonstrates our commitment to develop our businesses on a global scale, by investing in each region to support local strategic industries. We will continue to invest proactively to support this growth, matching closely the reality of the evolution of the demand."

Arkema produces PVDF in the USA, China, and France. All three sites have recently seen significant investment and capacity increase at a pace and with capabilities that match the evolution of the demand. 

Laurent Tellier, Senior Vice-President of Arkema’s High Performance Polymers...
Laurent Tellier, Senior Vice-President of Arkema’s High Performance Polymers and Fluorogases. © Arkema

Company

Logo:

Arkema

420 rue d’Estienne d’Orves
92705 Colombes Cedex
France

Company contact







Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read